Cosmetic Outcomes With Tissue Adhesive (2-octylcyanoacrylate) or Staples in Repeated Cesarean Section
Cosmetic Outcomes After Skin Closure of Pfannenstiel Incision With Tissue Adhesive (2-octylcyanoacrylate) or Staples in Repeated Cesarean Section
1 other identifier
interventional
80
1 country
1
Brief Summary
Recent clinical trials were developed to test the outcomes of skin closure with tissue adhesive, staples and monofilament synthetic suture after cesarean section with Pfannenstiel incision: both clinical outcomes such as blood loss, surgical site infection, length of postpartum hospitalization, or wound disruption, as well as Patient and Observer Scar Assessment Scale (POSAS) scores 8 weeks after surgery, were comparable between these different skin closure methods. Despite the available studies are often based on robust methodologies and appropriate assessment scales, most of them were aimed to evaluate cosmetic outcomes in primary cesarean section, whereas data analyses published so far do not allow to draw a firm conclusion about repeated cesarean sections. Based on these elements, the aim of this study is to evaluate cosmetic outcomes after skin closure of Pfannenstiel incision with tissue adhesive or staples in a selected population undergoing repeated cesarean section.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 5, 2020
CompletedFirst Posted
Study publicly available on registry
March 10, 2020
CompletedStudy Start
First participant enrolled
May 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2021
CompletedSeptember 8, 2021
August 1, 2021
9 months
March 5, 2020
August 31, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Observer Scar Assessment Scale (OSAS) score
The Observer Scar Assessment Scale (OSAS) rates 5 variables: vascularity, pigmentation, thickness, relief, and pliability. Each variable uses a 10-point scoring system, with 1 representing normal skin. Ratings of individual variables may be summed to obtain a total score ranging from 5-50, with 5 representing normal skin.
6 months after repeated cesarean section
Secondary Outcomes (1)
Patient Scar Assessment Scale (PSAS) score
6 months after repeated cesarean section
Study Arms (2)
Staples
ACTIVE COMPARATORWomen who underwent repeated cesarean section with skin closure using staples.
Tissue adhesive
EXPERIMENTALWomen who underwent repeated cesarean section with skin closure using 2-octylcyanoacrylate tissue adhesive.
Interventions
Eligibility Criteria
You may qualify if:
- Previous cesarean section with Pfannenstiel incision (regardless of the indication, emergency/urgency, weeks of pregnancy and years passed from the previous cesarean section)
- Maternal age 18-45 years
- Singleton pregnancy at 37-41 weeks of gestation (based on first-trimester ultrasound) with a viable fetus
You may not qualify if:
- History of keloids
- Previous transversal suprapubic scars
- Clinical signs of infection and/or tattoos in the area to be studied
- Known patient hypersensitivity to any of the suture materials used in the protocol
- BMI below 20 or above 30
- Any medical disorder that could affect wound healing, including severe malnutrition, conditions requiring chronic corticosteroid use or immune suppressant, uncontrolled diabetes mellitus (defined as Hemoglobin A1c \> 6%, unbalanced daily glucose measurements, and fasting glucose \>95 mg/dL).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ospedale "Filippo Del Ponte"
Varese, Lombardy, 21100, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonella Cromi, M.D., Ph.D.
Università degli Studi dell'Insubria
- STUDY CHAIR
Fabio Ghezzi, M.D.
Università degli Studi dell'Insubria
- STUDY CHAIR
Antonio Simone Laganà, M.D., Ph.D.
Università degli Studi dell'Insubria
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 5, 2020
First Posted
March 10, 2020
Study Start
May 15, 2020
Primary Completion
January 30, 2021
Study Completion
July 15, 2021
Last Updated
September 8, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share